Passive anti-amyloid beta immunotherapy in Alzheimer's disease-opportunities and challenges. Heneka MT, Morgan D, Jessen F. Lancet 2024 Nov 13:S0140-6736(24)01883-X. doi: 10.1016/S0140-6736(24)01883.

Read + Share

Amedeo Smart

Independent Medical Education

Heneka MT, Morgan D, Jessen F. Passive anti-amyloid beta immunotherapy in Alzheimer's disease-opportunities and challenges. Lancet 2024 Nov 13:S0140-6736(24)01883-X. doi: 10.1016/S0140-6736(24)01883.
PMID: 39549715